TABLE 2.

Heart rate and temperature during the treatment phase, restricted to samples with data available for the correction analysis

Sampling time	Heart rate			Temp (°C)			% (no./total no.) of patients with temp of >37. 7°C
	Median	IQRb	n	Median	IQR	n
Baseline	96	83–106	1,686	37.2	36.6–37.7	1,682	24.6 (414/1,682)
Month 1	81	71–95	1,562	36.6	36–37	1,582	2.7 (43/1,582)
Month 2	78	68–90	1,512	36.5	36–36.9	1,512	2.4 (37/1,539)
End of treatmenta	71	62–81	1,402	36.4	36–36.9	1,445	0.7 (10/1,445)

^aMonth 4 (gatifloxacin) or month 6 (control).

^bIQR, interquartile range.